Acadia(AKR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AKR Acadia

Not Yet Opened 10-29 16:00:00 EDT

19.07

+0.45

+2.42%

盘后19.07

+0.000.00%

19:30 EDT

High19.09	Low18.78	Vol883.81K
Open18.86	D1 Closing18.62	Amplitude1.64%
Mkt Cap2.62B	Tradable Cap2.61B	Total Shares137.33M
T/O16.77M	T/O Rate0.65%	Tradable Shares136.63M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"AKR","market":"US","secType":"STK","nameCN":"Acadia","latestPrice":19.07,"timestamp":1793304000000,"preClose":18.62,"halted":0,"volume":883810,"hourTrading":{"tag":"盘后","latestPrice":19.07,"preClose":19.07,"latestTime":"19:30 EDT","volume":20819,"amount":397022.83,"timestamp":1793316606818,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.024167561761546684,"floatShares":136629693,"shares":137332700,"eps":0.337883,"marketStatus":"Not Yet Opened","change":0.45,"latestTime":"10-29 16:00:00 EDT","open":18.86,"high":19.085,"low":18.78,"amount":16769250.08658,"amplitude":0.01638,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.337883,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1793347200000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":738475200000,"exchange":"NYSE","adjPreClose":18.62,"dividendRate":0.041961,"preHourTrading":{"tag":"盘前","latestPrice":18.62,"preClose":18.62,"latestTime":"04:00 EDT","volume":1,"amount":18.62,"timestamp":1793260811312,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":19.07,"preClose":19.07,"latestTime":"19:30 EDT","volume":20819,"amount":397022.83,"timestamp":1793316606818,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.783954,"impliedVol":0.1298,"impliedVolPercentile":0.2869},"requestUrl":"/m/hq/s/AKR","defaultTab":"news","newsList":[{"id":"1103031131","title":"Earning Preview: Acadia Realty Trust revenue is expected to decrease by 2.97%, and institutional views are broadly bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1103031131","media":"Earnings Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1103031131?lang=en_us&edition=fundamental","pubTime":"2026-10-26 13:09","pubTimestamp":1792991389,"startTime":"0","endTime":"0","summary":"Abstract Acadia Realty Trust will report quarterly results on November 2, 2026 Pre-MKt, and the preview centers on revenue near 89.68 million US dollars with earnings per share trends shaped by...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Earning Preview: Acadia Realty Trust revenue is expected to decrease by 2.97%, and institutional views are broadly bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679714034","title":"Acadia Realty Trust (AKR) Adds A New Trustee, Is It A Bargain?","url":"https://stock-news.laohu8.com/highlight/detail?id=2679714034","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679714034?lang=en_us&edition=fundamental","pubTime":"2026-10-29 17:33","pubTimestamp":1793266423,"startTime":"0","endTime":"0","summary":"Acadia Realty Trust (AKR) has added longtime REIT executive Tamara Fischer to its Board of Trustees and its Nominating and Corporate Governance Committee, giving investors a fresh governance angle to watch.\nAcadia Realty Trust’s share price has eased in recent months, with a 1-day share price return decline of 1.27% and a 90-day share price return down 16.99%. However, the 3-year total shareholder return of 44.87% suggests longer term holders have still seen solid value creation.\nSpot...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9551736-choice1-card/1788952954425","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9551736-choice1-card/1788952954425"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-akr/acadia-realty-trust/news/acadia-realty-trust-akr-adds-a-new-trustee-is-it-a-bargain","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-akr/acadia-realty-trust/news/acadia-realty-trust-akr-adds-a-new-trustee-is-it-a-bargain","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4080","BK4231","AKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677616010","title":"Acadia Realty Trust Files Initial Beneficial Ownership Statement for Director Tamara D Fischer","url":"https://stock-news.laohu8.com/highlight/detail?id=2677616010","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677616010?lang=en_us&edition=fundamental","pubTime":"2026-10-21 04:15","pubTimestamp":1792527351,"startTime":"0","endTime":"0","summary":"Acadia Realty Trust Files Initial Beneficial Ownership Statement for Director Tamara D FischerAcadia Realty Trust director Tamara D. Fischer filed an initial statement of beneficial ownership dated Oc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261020:nNDL9yS9Wc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKR","BK4231","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676163573","title":"Acadia Realty Trust Announces Appointment of Tamara Fischer to Board of Trustees","url":"https://stock-news.laohu8.com/highlight/detail?id=2676163573","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676163573?lang=en_us&edition=fundamental","pubTime":"2026-10-20 04:15","pubTimestamp":1792440900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261019:nTUA4LN3M3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AKR","BK4231","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676150204","title":"Acadia Pharmaceuticals Price Target Maintained with a $35.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2676150204","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676150204?lang=en_us&edition=fundamental","pubTime":"2026-10-19 18:18","pubTimestamp":1792405080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ACAD/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676499572","title":"Did Acadia Pharmaceuticals' Fall Catch You Out? What Investors Missed","url":"https://stock-news.laohu8.com/highlight/detail?id=2676499572","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676499572?lang=en_us&edition=fundamental","pubTime":"2026-10-19 09:43","pubTimestamp":1792374215,"startTime":"0","endTime":"0","summary":"Acadia Pharmaceuticals has had an attention grabbing year, from European approval of DAYBU for Rett syndrome to mixed Phase 2 data on remlifanserin that sparked legal investigations and analyst downgrades. Investors who held Acadia Pharmaceuticals from the start of the year are down 27.3%, including dividends. If you had been weighing a fresh position on 1 January 2026, how should these cross currents between DAYBU’s expansion and RADIANT’s stumble shape what you focus on next?\nNarratives are...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-acad/acadia-pharmaceuticals/news/did-acadia-pharmaceuticals-fall-catch-you-out-what-investors","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-acad/acadia-pharmaceuticals/news/did-acadia-pharmaceuticals-fall-catch-you-out-what-investors","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2065171311.SGD","ACAD","ISBC","BK4139","LU2065171402.SGD","LU2065170008.USD","AKR","BK4080","BK4231","LU2065169927.USD","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675677723","title":"Acadia Pharmaceuticals Price Target Cut to $23.00/Share from $49.00 by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2675677723","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675677723?lang=en_us&edition=fundamental","pubTime":"2026-10-14 05:00","pubTimestamp":1791925200,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ACAD/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675510313","title":"Acadia Realty Trust Schedules Third-Quarter 2026 Earnings Release, Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2675510313","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675510313?lang=en_us&edition=fundamental","pubTime":"2026-10-13 20:15","pubTimestamp":1791893714,"startTime":"0","endTime":"0","summary":"Acadia Realty Trust schedules third-quarter 2026 earnings release, conference callAcadia Realty Trust will release third-quarter 2026 earnings before the market opens on Nov. 2, 2026.Management will h","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261013:nNDL5rFnbV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","BK4231","AKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674806533","title":"Analysts’ Top Real Estate Picks: Welltower (WELL), Acadia Realty (AKR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2674806533","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674806533?lang=en_us&edition=fundamental","pubTime":"2026-10-12 22:40","pubTimestamp":1791816005,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Real Estate sector as 2 analysts just weighed in on Welltower (WELL) and Acadia Realty (AKR) with bulli...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-real-estate-picks-welltower-well-acadia-realty-akr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-real-estate-picks-welltower-well-acadia-realty-akr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RWR","AGNG","AVRE","BK4203","REZ","DFGR","GQRE","WELL","BBRE","BK4225","SCHH","URE","VGSR","LGLV","CLIM","IYRI","JRE","RNTY","HAUS","BK4585","RSPR","BK4231","ICF","IQRA","JPRE","IYR","FREL","DPRE","DFAR","VNQ","PSR","SPRE","REET","RITA","FRI","USRT","BK4080","XLRE","AKR","BYRE","REIT","RWO","BK4588","ERET","TRUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674827755","title":"US Research Roundup-Biogen, Datadog, Tesla","url":"https://stock-news.laohu8.com/highlight/detail?id=2674827755","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674827755?lang=en_us&edition=fundamental","pubTime":"2026-10-12 16:00","pubTimestamp":1791792031,"startTime":"0","endTime":"0","summary":"US RESEARCH ROUNDUP-Biogen, Datadog, TeslaOct 12 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several US-listed companies, including Biogen, Datadog and Tesla, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261012:nL4N45Y0F1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXG","ALHC","AIG","ALLY","AII","ALL","AMZN","AXP","AKR","APPN","APO","IBBQ","AMH","AVEX","ALSN","AFL","AAPL","COLD","IAK","VPU","AHR","JGRO","SPTE","AB","AHRT","ARE","APH","ADC","ABTC","IBB","ALKT","AFG","GGLS","AEP","LBO","AMGN","ASBH","ADM","ARMK","APG","AR","SAMZNmain","GOOGL","AME","APA","FTXG","ALX","ARES","ALH","AMG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674826478","title":"Acadia Realty Trust : Jefferies Cuts Target Price to $21 from $25","url":"https://stock-news.laohu8.com/highlight/detail?id=2674826478","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674826478?lang=en_us&edition=fundamental","pubTime":"2026-10-12 13:20","pubTimestamp":1791782443,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261012:nFWN45Y0Y2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AKR","BK4231","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673100354","title":"Acadia Pharmaceuticals Price Target Cut to $36.00/Share from $37.00 by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2673100354","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673100354?lang=en_us&edition=fundamental","pubTime":"2026-10-08 22:10","pubTimestamp":1791468600,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ACAD/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673086090","title":"Acadia looks to have settled case with Zydus, says RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2673086090","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673086090?lang=en_us&edition=fundamental","pubTime":"2026-10-06 01:35","pubTimestamp":1791221721,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Brian Abrahams says the firm’s checks found that Acadia Pharmaceuticals (ACAD) and generic drugmaker Zydus filed a joint stipul...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/acadia-looks-to-have-settled-case-with-zydus-says-rbc-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/acadia-looks-to-have-settled-case-with-zydus-says-rbc-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065171402.SGD","LU0128525929.USD","ACAD","BK4139","LU0029864427.USD","BK4080","LU1267930573.SGD","BK4231","LU2065171311.SGD","LU0708994859.HKD","GSIB","LU2065170008.USD","LU2065169927.USD","LU0310800379.SGD","AKR","BK4207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672174896","title":"Acadia Realty Trust Coverage Assumed by Truist Securities at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2672174896","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672174896?lang=en_us&edition=fundamental","pubTime":"2026-10-02 23:26","pubTimestamp":1790954760,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AKR/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","BK4231","AKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672719174","title":"Truist Lowers Price Target on Acadia Realty Trust to $22 From $24, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2672719174","media":"MT Newswires Live","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672719174?lang=en_us&edition=fundamental","pubTime":"2026-10-02 19:20","pubTimestamp":1790940023,"startTime":"0","endTime":"0","summary":"Acadia Realty Trust (AKR) has an average rating of buy and mean price target of $24.67, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672719553","title":"Acadia Realty Trust : Truist Securities Assumes Coverage with Buy Rating; Price Target $22","url":"https://stock-news.laohu8.com/highlight/detail?id=2672719553","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672719553?lang=en_us&edition=fundamental","pubTime":"2026-10-02 19:09","pubTimestamp":1790939364,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O10T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4080","AKR","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672925762","title":"Truist Financial Keeps Their Buy Rating on Acadia Realty (AKR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672925762","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672925762?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:35","pubTimestamp":1790886941,"startTime":"0","endTime":"0","summary":"In a report released today, Michael Lewis from Truist Financial maintained a Buy rating on Acadia Realty, with a price target of $22.00. According ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/truist-financial-keeps-their-buy-rating-on-acadia-realty-akr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/truist-financial-keeps-their-buy-rating-on-acadia-realty-akr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671301268","title":"Acadia Pharmaceuticals Gets US Patent Office Allowance for Trofinetide Dosing Patent","url":"https://stock-news.laohu8.com/highlight/detail?id=2671301268","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671301268?lang=en_us&edition=fundamental","pubTime":"2026-09-29 05:17","pubTimestamp":1790630276,"startTime":"0","endTime":"0","summary":"Acadia Pharmaceuticals  said late Monday the US Patent and Trademark Office issued a notice of allowance for a patent application covering weight-banded dosing of trofinetide for the treatment of Rett syndrome.The company said the patent, if issued, is expected to provide US protection for trofinetide through March 28, 2041, including six months of pediatric exclusivity, extending protection by nearly five years.Trofinetide is marketed in the US as \"Daybue\" and \"Daybue Stix\" for the treatment of Rett syndrome in adults and children age 2 and older. The drug is also covered by a method-of-use patent that expires in July 2036, the company said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ACAD","AKR","LU2065169927.USD","BK4231","LU2065171402.SGD","USRD","BK4080","LU2065170008.USD","BK4139","LU2065171311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670542610","title":"Acadia Pharmaceuticals' Risk-Reward Favorable After Remlifanserin Data, Deutsche Bank Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2670542610","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670542610?lang=en_us&edition=fundamental","pubTime":"2026-09-26 00:34","pubTimestamp":1790354048,"startTime":"0","endTime":"0","summary":"Acadia Pharmaceuticals'  favorable risk-reward remains intact despite remlifanserin narrowly missing statistical significance in a phase 2 trial in Alzheimer's disease psychosis, with the commercial base business supporting valuation, Deutsche Bank said in a Friday note.The 60 milligram dose narrowly missed statistical significance, but Deutsche Bank said the data showed a dose response, separation from placebo beginning at Week 2 and widening through Week 6, and a clean safety profile.The bank said remlifanserin has a pimavanserin-like profile that could be attractive commercially, supported by long-dated intellectual property.Deutsche Bank also cited improving commercial prospects for Nuplazid and Daybue.The investment bank reduced its probability of success for remlifanserin in Alzheimer's disease psychosis and Lewy body dementia psychosis.Deutsche Bank maintained its Buy rating and lowered its price target to $31 from $38.Shares of Acadia were 5.7% lower in Friday afternoon trading","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ACAD","LU2065170008.USD","BK4552","BK4566","BK4080","DB","BK4118","AKR","LU2065171311.SGD","LU2065171402.SGD","BK4585","BK4139","BK4231","BK4588","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670294423","title":"Acadia Pharmaceuticals is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2670294423","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670294423?lang=en_us&edition=fundamental","pubTime":"2026-09-25 22:52","pubTimestamp":1790347920,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ACAD/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKR"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.acadiarealty.com","stockEarnings":[{"period":"1week","weight":0.0154},{"period":"1month","weight":-0.0068},{"period":"3month","weight":-0.1513},{"period":"6month","weight":-0.1134},{"period":"1year","weight":-0.001},{"period":"ytd","weight":-0.0716}],"compareEarnings":[{"period":"1week","weight":0.0071},{"period":"1month","weight":0.0068},{"period":"3month","weight":0.0299},{"period":"6month","weight":0.0676},{"period":"1year","weight":0.1192},{"period":"ytd","weight":0.1282}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Acadia Realty Trust is an equity real estate investment trust focused on delivering long-term, profitable growth via its dual  Core Portfolio and Fund  operating platforms and its disciplined, location-driven investment strategy. Acadia Realty Trust is accomplishing this goal by building a best-in-class core real estate portfolio with meaningful concentrations of assets in the nation's most dynamic corridors; making profitable opportunistic and value-add investments through its series of discretionary, institutional funds; and maintaining a strong balance sheet.","yearOnYearQuotes":[{"month":1,"riseRate":0.606061,"avgChangeRate":0.019474},{"month":2,"riseRate":0.515152,"avgChangeRate":0.00617},{"month":3,"riseRate":0.606061,"avgChangeRate":-0.008102},{"month":4,"riseRate":0.484848,"avgChangeRate":0.015676},{"month":5,"riseRate":0.424242,"avgChangeRate":-0.005165},{"month":6,"riseRate":0.5,"avgChangeRate":0.001528},{"month":7,"riseRate":0.617647,"avgChangeRate":0.018179},{"month":8,"riseRate":0.470588,"avgChangeRate":-0.004795},{"month":9,"riseRate":0.411765,"avgChangeRate":-0.00845},{"month":10,"riseRate":0.529412,"avgChangeRate":-0.003893},{"month":11,"riseRate":0.515152,"avgChangeRate":0.013024},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.008041}],"exchange":"NYSE","name":"Acadia","nameEN":"Acadia"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.1","shortVersion":"4.52.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Acadia(AKR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Acadia(AKR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Acadia,AKR,Acadia股票,Acadia股票老虎,Acadia股票老虎国际,Acadia行情,Acadia股票行情,Acadia股价,Acadia股市,Acadia股票价格,Acadia股票交易,Acadia股票购买,Acadia股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Acadia(AKR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Acadia(AKR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction